Rationale: Myasthenia gravis (MG) is an uncommon autoimmune disease mediated by antibodies that attack the postsynaptic acetylcholine receptors (AchRs) at the neuromuscular junction, causing fluctuating muscle weakness, aggravated with use, and relieved with rest.
Introduction
Myasthenia gravis (MG) is an uncommon autoimmune disease mediated by antibodies that attack the postsynaptic acetylcholine receptors (AchRs) at the neuromuscular junction (NMJ), causing fluctuating muscle weakness aggravated with use and relieved with rest. Its 2 main forms are ocular, which is restricted to the eyelid and extraocular musculature and may be asymmetrical, and the generalized form, in which there is also involvement of the bulbar, respiratory muscles, and limbs in varying degrees, but maintains the symmetry of the affected site. [1] In this report, we describe a patient that was admitted with generalized reduction of force, but with an exuberant asymmetry between the body sides, being predominant in the left. The clinical history and the complementary examinations allowed the diagnostic confirmation of MG and an adequate therapeutic management.
Case report
A 32-year-old woman presented with dysphagia, dysphonia, diplopia, and intense weakness, most evident in the left side of the body, concomitant with noninflammatory diarrhea, nausea, and vomiting, without fever or abdominal pain. She reported a diagnosis 1 year before of MG based on clinical history (dysphagia, dysphonia, diplopia, and palpebral ptosis, more intense throughout the day and always with an exuberant predominance in left arm and leg), electroneuromyography A written informed consent was given by the patient for publication of this study and any accompanying images.
The authors have no funding and conflicts of interest to disclose. ( Fig. 1) , and normal magnetic resonance imaging (MRI) of the brain. She denied any other comorbidity. The symptoms were controlled with pyridostigmine and prednisone.
Physical examination revealed right palpebral ptosis with isochoric and photoreactive pupils, globally reduced deep tendon reflexes, and tetraparesis, with muscle strength grade 4 in the left limbs and grade 2 in the right limbs. The rest of the clinical examination was unchanged.
Levels of serum anti-acetylcholine receptors (anti-AchRs) were increased (>20 nmol/L), while levels of thyroid hormone and muscle enzymes showed no abnormalities. A chest computed tomography (CT) showed a thymic remnant (Fig. 2) . After reviewing previous examinations, evaluating the clinical history, and hospitalization examinations, we doubled the dose of pyridostigmine via nasogastric catheter and administered human immunoglobulin for 5 days. After 72 hours of treatment, the patient presented significant improvement, being discharged 7 days later with significant symptoms improvement ( Fig. 3 ) with pyridostigmine 600 mg/d, prednisone 10 mg/d, and azathioprine 100 mg/d, and was referred for ambulatory follow-up. Her symptoms are still well controlled 6 months later. The patient was evaluated by a thoracic surgeon and is awaiting elective thymectomy.
Discussion
We report an uncommon presentation of MG, an autoimmune disease associated with impairment of neuromuscular transmission, due to an immunomediated reaction against postsynaptic membrane proteins of the NMJ. Clinically, it may present as ocular MG, restricted to ocular and extraocular musculature, and generalized, affecting other muscle groups. In both forms, there is a marked fluctuation of skeletal muscle strength, which can lead to fatigue of muscle groups, which is reflected in the clinical manifestation: diplopia and palpebral ptosis (ocular), dysarthria, dysphagia and weak mastication (bulb), and involvement of proximal musculature, with greater expression in the hands (limbs). [1] The diagnosis of MG is based on clinical history, physical examination, serologic examination, and electrophysiologic studies (study of repetitive nerve stimuli and single fiber electroneuromyography). The serologic test consists of the On the contrary, anti-MusK is present in 38% to 50% of MG carriers with anti-AChR negative. [2] The last step in the diagnosis of MG is electrophysiologic studies. In the study of repetitive nerve stimulation, there is a reduction of the muscular action potential with the repetition of the stimulus. In the single fiber electroneuromyography, responsible for evaluating the action potential in 2 distinct but innervated muscles by the same neuron, there is an increase in the time variation between the action potentials of the muscles, reflecting a weak transmission. [3] The MG therapy includes acetylcholinesterase inhibitors (i.e., pyridostigmine), immunomodulators such as glucocorticoids and immunosuppressants (i.e., azathioprine, mycophenolate mofetila, and cyclosporine), rapid immunomodulation (i.e., plasmapheresis and intravenous immunoglobulin), and thymectomy in selected cases. [4] Our patient fulfilled all diagnostic criteria: clinical (worsening of symptoms throughout the day, in the presence of inflammatory intercurrences, and with significant improvement with acetylcholinesterase inhibitors), laboratory (presence of high levels of anti-AchR), and electroneuromiographic (decreased amplitude by more than 10% in electroneuromyography with repetitive stimuli). It is noteworthy that at admission, the patient presented severe symptoms of oropharyngeal involvement, which often precede the so-called myasthenic crisis, when there is a severe involvement of the respiratory muscles, implying the need for intubation for ventilatory support. [5] The presence of thymic remnant in the chest CT caused the patient to be referred for further evaluation by a thoracic surgeon, aiming a better control of MG. [4] However, the markedly asymmetric limb weakness presented in previous history and clinical examination of admission was an unusual and unexpected presentation, especially considering the pathophysiology of the disease. MRI of brain without abnormalities was fundamental to rule out another associated etiology, such as ischemic insult, vasculitis, or demyelinating disease.
Our review of the literature [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] on unusual forms of MG manifestation revealed just 1 case report of MG [6] with a similar presentation even considering a large series of atypical case reports. [7] This clinical manifestation becomes valuable because it contributes to the list of unexpected presentation that should motivate its suspicion. 
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